Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Bellicum Pharmaceuticals Q2 EPS $(0.22) Up From $(7.81) YoY

Bellicum Pharmaceuticals (NASDAQ:BLCM) reported quarterly losses of $(0.22) per share. This is a 97.18 percent increase over losses of $(7.81) per share from the same period last year.
byBill Haddad
August 12, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Bellicum Pharmaceuticals (NASDAQ:BLCM) reported quarterly losses of $(0.22) per share. This is a 97.18 percent increase over losses of $(7.81) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts